News for BioNTech SE - ADR (22UA.DE)

U.S. stock futures declined on Monday after a small bout of relief on Friday as indices neared the correction zone.

U.S. stocks were mostly lower, with the Nasdaq Composite falling around 100 points on Wednesday. Shares of Electronic Arts Inc EA rose sharply during Wednesday...

To gain an edge, this is what you need to know today.

In this article, we will take a detailed look at the Jim Cramer is Recommending These 10 Stocks. For a quick overview of such stocks, read our article Jim Cramer is Recommending These 5 Stocks. Jim Cramer said in a latest program on CNBC that “all is not well in corporate America.” Cramer was referring to weak earnings […]

Jim Cramer said in a latest program on CNBC that "all is not well in corporate America." Cramer was referring to weak earnings which according to him show that the state of the economy is "sluggish." ...

BNTX | A complete BNTX overview by MarketWatch. View the latest market news and prices, and trading information.

The BioNTech SE ADR shed 2.50% to $90.91 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling...

Dear Fellow Shareholders,For the six months ended April 30, 2023, the PRIMECAP Odyssey Stock Fund, PRIMECAP Odyssey Growth Fund, and PRIMECAP Odyssey Aggressive

In the midst of a seemingly constant hum of summer activity, something from the past is looming large again: COVID-19. What Happened: New data from the Centers...

The BioNTech SE ADR slid 2.26% to $107.46 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...

The BioNTech SE ADR slumped 0.35% to $108.05 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...

EQS-News: Organicell Regenerative Medicine, Inc. Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier? 10.11.2022 /... | November 10, 2022

Johnson & Johnson's (NYSE: JNJ) single-shot coronavirus vaccine candidate has been cleared as the third vaccine in the U.S. for emergency use, a day ...

Biotech stocks extended their losses in the week ended Feb. 26 amid continued weakness in the broader market. Earnings came in thick and fast, with a skew ...

Johnson & Johnson's (NYSE: JNJ) coronavirus vaccine candidate could be given clearance for emergency use today, following unanimous backing by a ...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 19) ...

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 16) 10X ...

The winter storm that has blanketed large parts of the U.S. in snow and ice has disrupted the COVID-19 vaccine program, forcing clinics and sites across the...

U.K. nationals arriving in England from high-risk countries will be charged £1,750 ($2,433) for their 10-day stays.